These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Migration inhibitory test and its clinical aspects]. Dobozy A; Hunyadi J; Simon N Berufsdermatosen; 1973 Aug; 21(4):137-51. PubMed ID: 4583667 [No Abstract] [Full Text] [Related]
5. Transfer factor in cellular immunity. Lawrence HS Harvey Lect; 1974; 68():239-350. PubMed ID: 4616018 [No Abstract] [Full Text] [Related]
6. [Lymphocyte migration inhibition test in (MIT) in collagen diseases]. Del Rey Calero J; Calbo Torrecillas F Rev Sanid Hig Publica (Madr); 1970 Dec; 44(12):1367-82. PubMed ID: 5525223 [No Abstract] [Full Text] [Related]
7. Production of macrophage inhibitory factor by patients with leprosy. Katz SI; DeBetz BH; Zaias N Arch Dermatol; 1971 Apr; 103(4):358-61. PubMed ID: 5091865 [No Abstract] [Full Text] [Related]
8. [Lymphokines, with special reference to skin reactive factor (SRF) (author's transl)]. Aoki T Rinsho Byori; 1981 Dec; 29(12):1223-7. PubMed ID: 7040741 [No Abstract] [Full Text] [Related]
9. In vitro lymphocyte response of patients with immunologic deficiency diseases. Rocklin RE; Rosen FS; David JR N Engl J Med; 1970 Jun; 282(24):1340-3. PubMed ID: 5444647 [No Abstract] [Full Text] [Related]
10. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. David JR; David RR Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107 [No Abstract] [Full Text] [Related]
11. Role of macrophages in immunity, with special reference to tumour immunology. A review. Lejeune FJ Biomedicine; 1975 Jan; 22(1):25-34. PubMed ID: 1180973 [TBL] [Abstract][Full Text] [Related]
12. Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity. Yoshida T; Cohen S J Immunol; 1974 Apr; 112(4):1540-7. PubMed ID: 4131167 [No Abstract] [Full Text] [Related]
13. Comparison of lymphocyte transformation, inhibition of macrophage migration and skin tests using dialyzable and nondialyzable tuberculin fractions from Mycobacterium bovis (BCG). Chaparas SD; Thor DE; Hedrick SR J Immunol; 1971 Jul; 107(1):149-53. PubMed ID: 4933403 [No Abstract] [Full Text] [Related]
15. The effect of lymphokines on the development of delayed hypersensitivity to an unrelated antigen. Krejcí J; Pekàrek J; Svejcar J; Johanovskỳ J Immunology; 1973 Nov; 25(5):875-9. PubMed ID: 4761637 [TBL] [Abstract][Full Text] [Related]
16. Immunologic problems encountered in hematology. Hill JM; Khan A Ann Allergy; 1972 Oct; 30(10):562-74. PubMed ID: 4262891 [No Abstract] [Full Text] [Related]
18. The role of delayed hypersensitivity in immunological processes and its relationship to aphthous stomatitis. Oppenheim JJ; Francis TC J Periodontol; 1970 Apr; 41(4):205-9. PubMed ID: 4194166 [No Abstract] [Full Text] [Related]
19. Effect of transfer factor on lymphocyte function in anergic patients. Kirkpatrick CH; Rich RR; Smith TK J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419 [TBL] [Abstract][Full Text] [Related]
20. Human skin responses to products of concanavalin A-activated lymphocytes. Valdimarsson H; Gross NJ J Immunol; 1973 Aug; 111(2):485-91. PubMed ID: 4717991 [No Abstract] [Full Text] [Related] [Next] [New Search]